Your session is about to expire
← Back to Search
AIR Sleep Treatment for PTSD-related Sleep Disorders (AIR Trial)
AIR Trial Summary
This trial will test whether a sleep treatment can help improve sleep and functioning in Veterans with PTSD.
AIR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAIR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.AIR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have recently changed or plan to change my medication for depression, anxiety, or sleep.You have symptoms that match the diagnosis for Posttraumatic Stress Disorder in the DSM-5 or similar related symptoms.You do not have a stable place to live.I have no travel or personal plans that would interfere with regular treatment.You have been diagnosed with insomnia according to the DSM-5 guidelines.You have sleep problems that could affect your treatment, as decided by the main doctor in charge.I can read, understand, and communicate in English well enough for treatment and assessments.I have been diagnosed with PTSD or have symptoms of PTSD.You have experienced severe mental illness like hallucinations or extreme mood swings in the last 5 years.I am a veteran diagnosed with sleep apnea and advised to use a PAP machine.You have had a serious problem with drugs or alcohol in the last 6 months.You work at night or have a job that requires working different shifts, including at night.You have been diagnosed with insomnia disorder according to the DSM-5 guidelines.I recently started or stopped therapy for sleep or mental health issues.I have severe thoughts of harming myself or others.
- Group 1: Apnea and Insomnia Relief (AIR)
- Group 2: Sleep Education (SE)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential perils might arise from using Apnea and Insomnia Relief (AIR)?
"The safety of Apnea and Insomnia Relief (AIR) was evaluated to be a 2 on the scale, as this is only in Phase 2. This implies there is evidence that it's safe, but not yet any proof of its efficacy."
Is enrolment for this trial still ongoing?
"According to clinicaltrials.gov, this research trial is currently accepting patient candidates. The proposal was originally listed on February 27th 2020 and the last update occurred on January 12th 2022."
How many participants have been enrolled in this trial thus far?
"Affirmative, according to clinicaltrials.gov the trial was initially announced on February 27th 2020 and is currently recruiting participants with a goal of 80 patients across only 1 medical centre."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger